Clinical Trials Directory

Trials / Completed

CompletedNCT06287502

Efficacy of Structured Exercise-Nutritional Intervention on Sarcopenia in Patients With Osteoporosis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
13 (actual)
Sponsor
Kowloon Hospital, Hong Kong · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This is a prospective parallel group, double-blinded randomized controlled trial. Subjects are randomized into two groups - the intervention group and waitlist control group. Subjects received resistance, aerobic, flexibility and balance exercise training; and nutritional supplement containing β-hydroxy β-methylbutyrate (HMB). The intervention group would first receive the intervention during the 12-week study period. Meanwhile, the waitlist control group would receive 12 weeks of conventional care. After the study period, they would receive the same intervention.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTβ-hydroxy β-methylbutyrate (HMB)Ensure NutriVigor, a nutritional supplement, was provided to subjects according to the manufacturer's recommendation of two servings per day. Each serving consists of 54.1g of powder which provides \~231kcal, 8.61g protein, 1.21 g β-hydroxy β-methylbutyrate, 130 IU vitamin D and 0.29 g omega-3 fatty acid.
BEHAVIORALResistance, aerobic, flexibility and balance exercise trainingThe exercise intervention consists of 75-minutes sessions delivered by physiotherapists at the Integrated Rehabilitation Day Centre (IRDC) in Kowloon Hospital, twice per week for 12 weeks with a total of 24 supervised sessions. Each exercise session consists of 5 minutes of warm up, 30 minutes of resistance training, 20 minutes of aerobic training, 15 minutes of balance or neuromuscular exercises and 5 minutes of cool down.

Timeline

Start date
2022-09-09
Primary completion
2024-04-30
Completion
2024-06-30
First posted
2024-03-01
Last updated
2025-09-23

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT06287502. Inclusion in this directory is not an endorsement.